Periconceptional multivitamin intake during early pregnancy, genetic variation of acetyl-N-transferase 1 (NAT1), and risk for orofacial clefts

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 70, Issue 11, 2004, Pages 846-852

  Lammer, Edward J ^a   Shaw, Gary M ^b   Iovannisci, David M ^a   Finnell, Richard H ^c  

^a CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^b California Birth Defects Monitoring Program   (United States)

^c TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Cleft lip; Cleft palate; Folates; Folic acid; Gene environment interaction; Multivitamins; N acetyltransferase; NAT1

Indexed keywords

MULTIVITAMIN;

ACETYL N TRANSFERASE 1 GENE; ARTICLE; BIRTH DEFECT; CLEFT FACE; CONTROLLED STUDY; FEMALE; FETUS; FIRST TRIMESTER PREGNANCY; GENE; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HIGH RISK POPULATION; HOMOZYGOSITY; HUMAN; INFANT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MOTHER; NEURAL TUBE DEFECT; OROFACIAL CLEFT; POPULATION RESEARCH; PREGNANCY; PRIORITY JOURNAL; RISK FACTOR; UNITED STATES; WILD TYPE;

ADULT; ARYLAMINE N-ACETYLTRANSFERASE; CASE-CONTROL STUDIES; CLEFT LIP; CLEFT PALATE; COHORT STUDIES; DIETARY SUPPLEMENTS; FEMALE; FOLIC ACID; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; ISOENZYMES; MALE; POLYMORPHISM, GENETIC; PRECONCEPTION CARE; PREGNANCY; RISK FACTORS; VARIATION (GENETICS);

EID: 10044281543     PISSN: 15420752     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdra.20081     Document Type: Article

References (38)

1. Ambrosone CB, Freudenheim JL, Graham S, et al. 1996. Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. JAMA 276:1494-1501.
2. Bell DA, Badawi AF, Lang NP, et al. 1995. Polymorphism in the N-acetyltransferase 1 (NAT1) polyadenylation signal: association of NAT1*10 allele with higher N-acetylation activity in bladder and colon tissue. Cancer Res 55:5226-5229.
3. Brockton N, Little J, Sharp L, Cotton SC. 2000. N-Acetyltransferase polymorphisms and colorectal cancer: a HuGE review. Am J Epidemiol 151:846-861.
4. Bunschoten A, Tiemersma E, Schouls L, Kampman E. 2000. Simultaneous determination of polymorphism of N-acetyltransferases 1 and 2 genes by reverse line blot hybridization. Anal Biochem 285:156-162.
5. Chen J, Stempfer MJ, Hough HL, et al. 1998. A prospective study of N-acetyltransferase genotype, red meat intake, and risk of colorectal cancer. Cancer Res 58:3307-3311.
6. Czeizel A, Dudas I. 1992. Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. N Engl J Med 327:1832-1835.
7. de León JH, Vatsis KP, Weber WW. 2000. Characterization of naturally occurring and recombinant human N-acetyltransferase variants encoded by NAT1. Mol Pharmacol 58:288-299.
8. Dempster A, Laird N, Rubin D. 1977. Maximum likelihood from incomplete data via the EM algorithm. J R Stat Soc Ser B Stat Methodol 39:1-38.
9. Dietz AC, Doll MA, Hein DW. 1997. A restriction fragment length polymorphism assay that differentiates human N-acetyltransferase-1 (NAT1) alleles. Anal Biochem 253:219-224.
10. Excoffier L, Slatkin M. 1995. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 12:921-927.
11. Hayes C, Werler MM, Willett WC, Mitchell AA. 1996. Case-control study of periconceptional folic acid supplementation and oral clefts. Am J Epidemiol 143:1229-1234.
12. Hedrick PW. 1987. Gametic disequilibrium measures: proceed with caution. Genetics 117:331-341.
13. Hill L, Murphy M, McDowell M, Paul AH. 1988 Maternal drug histories and congenital malformations: limb reduction defects and oral clefts. J Epidemiol Community Health 42:1-7.
14. Hughes NC, Janezic SA, McQueen JL, et al. 1998. Identification and characterization of variant alleles of human acetyltransferase NAT1 with defective function using p-aminosalicylate as an in-vivo and in-vitro probe. Pharmacogenetics 1998;8:55-66.
15. Iovannisci DM. 2000. Highly efficient recovery of DNA from dried blood using the MasterPure complete DNA and RNA purification kit. Epicentre Forum 7:6-8.
16. Itakala PR, Watkins ML, Mulinare J, et al. 2001. Maternal multivitamin use and orofacial clefts in offspring. Teratology 63:79-86.
17. Khoury MJ, Gomez-Frias M, Mulinare J. 1989. Does maternal cigarette smoking during pregnancy cause cleft lip and palate in the offspring? Am J Dis Child 143:333-337.
18. Lammer EJ, Shaw GM, Iovannisci DM, et al. 2004. Maternal smoking during pregnancy, genetic variation of N-acetyltransferases NAT1 and NAT2, and risk for orofacial clefts. Epidemiology 15:150-156.
19. Lancaster A, Nelson MP, Single RM, et al. 2003. PyPop: a software framework for population genomics: analyzing large-scale multi-locus genotype data. In: Altman RB, et al. Pacific Symposium on Biocomputing 8, Singapore: World Scientific. pp. 514-525.
20. Lin HJ, Han C-Y, Lin BK, Hardy S. 1993. Slow acetylator mutations in the human polymorphic N-acetyltransferase gene in 786 Asians, blacks, Hispanics, and whites: application to metabolic epidemiology. Am J Hum Genet 52:827-834.
21. McPartin J, Halligan A, Scott JM. 1993. Accelerated folate breakdown in pregnancy. Lancet 341:148-149.
22. Miller SA, Dykes DD, Polesky HR. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215.
23. Millikan RC, Pittman GS, Newman B, et al. 1998. Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 7:371-378.
24. Minchin RF. 1995. Acetylation of p-aminobenzoylglutamate, a folic acid catabolite, by recombinant human arylamine N-acetyltransferase and U937 cells. Biochem J 307(Pt 1):1-3.
25. Mitchell MK, Futscher BW, McQueen CA. 1999. Developmental expression of N-acetyltransferases in C57B1/6 mice. Drug Metab Dispos 27:261-264.
26. MRC Vitamin Study Research Group. 1991. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338:131-137.
27. Mulinare J, Cordero JF, Erickson JD, Berry RJ. 1988. Periconceptional use of multivitamins and occurrence of neural tube defects. JAMA 260:3141-3145.
28. Probst-Hensch NM, Haile RW, Li DS, et al. 1996. Lack of association between the polyadenylation polymorphism in the NAT1 (acetyltransferase 1) gene and colorectal adenomas. Carcinogenesis 17:2125-2129.
29. Rhodes RB, Lewis K, Shultz J, et al. 2001. Analysis of the factor V Leiden mutation using the READIT™ assay. Mol Diagn 6:55-61.
30. Shaw GM, Lammer EJ. 1997. Incorporating molecular genetic variation and environmental exposures into epidemiologic studies of congenital anomalies. Reprod Toxicol 11:275-280.
31. Shaw GM, Schaffer D, Velie EM, et al. 1995a. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology 6:1-8.
32. Shaw GM, Lammer EJ, Wasserman CR, et al. 1995b. Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally. Lancet 346:393-396.
33. Sim E, Payton M, Noble M, Minchin R. 2000. An update on genetic, structural and functional studies of arylamine N-acetyltransferases in eucaryotes and procaryotes. Hum Mol Genet 9:2435-2441.
34. Smelt VA, Upton A, Adjaye J, et al. 2000. Expression of arylamine N-acetyltransferases in pre-term placentas and in human pre-implantation embryos. Human Mol Genet 9:1101-1107.
35. Stanley LA, Copp AJ, Pope J, et al. 1998. Immunochemical detection of arylamine N-acetyltransferase during mouse embryonic development and in adult mouse brain. Teratology 58:174-182.
36. Upton A, Johnson N, Sandy J, Sim E. 2001. Arylamine N-acetyltransferases: of mice, men and microorganisms. Trends Pharmcol Sci 22:140-146.
37. Ward A, Summers MJ, Sim E. 1995. Purification of recombinant human N-acetyltransferase type 1 (NAT1) expressed in E. coli and characterization of it potential role in folate metabolism. Biochem Pharmacol 49:1759-1767.
38. Werler MM, Shapiro S, Mitchell AA. 1993. Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA 269:1257-1261.